Thomas R. Kuhn - 22 Jan 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Reporting relationship: Director, Chairman
Issuer ticker: ATEX
Reported as of: 22 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jan 2025, 17:24:51 UTC
Prior SEC filing: 14 Jan 2025
Next SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Thomas R. Kuhn filed Form 4 for Anterix Inc. (ATEX) on 24 Jan 2025.

Key facts

This page summarizes Thomas R. Kuhn's Form 4 filing for Anterix Inc. (ATEX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jan 2025, 17:24.

Change

Previous filing in this sequence was filed on 14 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATEX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +56,803
Change %
Price: $0.000000
Shares after: 56,803
Date: 22 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 56,803
Exercise price: $29.84
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shares shall vest in full and become exercisable on January 22, 2028, subject to the Reporting Person's continued service with the Issuer through this date.